Humulin l and Death - a phase IV clinical study of FDA data

Summary:

Death is reported as a side effect among people who take Humulin l (insulin zinc susp recombinant human), especially for people who are male, 60+ old, have been taking the drug for 1 - 2 years also take Ferrous Fumarate, and have Diabetes.

The study is created by eHealthMe based on reports of 475 people who have side effects when taking Humulin l from the FDA, and is updated regularly.

What is Humulin l?

Humulin l has active ingredients of insulin zinc susp recombinant human. eHealthMe is studying from 476 Humulin l users. Check the latest studies of Humulin l.

On Jul, 14, 2026

475 people reported to have side effects when taking Humulin l.
Among them, 14 people (2.95%) died.

Among these 14 people:

How long have people been on Humulin l when they died? *

What is the gender of people who died when taking Humulin l? *

female: 0.0 %
male: 100 %

What is the age of people who died when taking Humulin l? *

What are other drugs people take besides Humulin l? *

What are other side effects people have before they died? *

Palmar-Plantar Erythrodysaesthesia Syndrome (hand-foot syndrome): 3 people, 21.43%
International Normalised Ratio Increased: 2 people, 14.29%
Mucosal Inflammation (infection of mucous membrane): 2 people, 14.29%
Hair Loss: 2 people, 14.29%
Insomnia (sleeplessness): 2 people, 14.29%
Fatigue (feeling of tiredness): 2 people, 14.29%
Constipation: 2 people, 14.29%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 2 people, 14.29%
Chronic Kidney Disease: 2 people, 14.29%
Rashes (redness): 2 people, 14.29%

What are the existing conditions these people have? *

Diabetes: 6 people, 42.86%
Type 2 Diabetes: 5 people, 35.71%
Pain: 4 people, 28.57%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 3 people, 21.43%
Blood Pressure Abnormal: 3 people, 21.43%
Cardiac Disorder: 2 people, 14.29%
Constipation: 2 people, 14.29%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 14.29%
Lung Cancer - Non-Small Cell (lung cancer): 2 people, 14.29%
Bladder Transitional Cell Carcinoma (types of bladder cancer): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Humulin l:

Humulin l (476 reports)

Expand to all the drugs that have ingredients of insulin zinc susp recombinant human:

Death and drugs with ingredients of insulin zinc susp recombinant human (15 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Humulin l:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Death:

Death (3,128 drugs)

Browse all the conditions that are associated with Death:

Death (3,686 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on insulin zinc susp recombinant human (the active ingredients of Humulin l) and Humulin l (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.